At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function - a Multi-center, Double-blind, Randomized, Placebo-controlled Clinical Trial - SERVE Trial
In Brief
A Phase 3 clinical trial evaluating Tadalafil 20 MG and Placebo 20 MG for Heart Defects, Congenital and Transposition of Great Vessels With Ventricular Inversion. Completed, enrolled 100 participants across 7 sites in 2 countries.
Detailed Summary
This study assesses in a double-blind, randomized, placebo-controlled multi-center pilot trial the effect of PDE-5 inhibition with Tadalafil on right ventricle size and function, exercise capacity and neurohumoral activation in adults with congenital heart disease and a right ventricle in subaortic position over a 3-year follow-up period.
Study Details
Timeline
Interventions
Multi-center, double-blind, 1:1 randomized, placebo-controlled clinical trial with Tadalafil
Multi-center, double-blind, 1:1 randomized, placebo-controlled clinical trial with Tadalafil